Literature DB >> 17420465

A missense mutation in the 3-ketodihydrosphingosine reductase FVT1 as candidate causal mutation for bovine spinal muscular atrophy.

Stefan Krebs1, Ivica Medugorac, Susanne Röther, Katja Strässer, Martin Förster.   

Abstract

The bovine form of the autosomal recessive neurodegenerative disease spinal muscular atrophy (SMA) shows striking similarity to the human form of the disease. It has, however, been mapped to a genomic region not harboring the bovine orthologue of the SMN gene, mutation of which causes human SMA. After refinement of the mapping results we analyzed positional and functional candidate genes. One of three candidate genes, FVT1, encoding 3-ketodihydrosphingosine reductase, which catalyzes a crucial step in the glycosphingolipid metabolism, showed a G-to-A missense mutation that changes Ala-175 to Thr. The identified mutation is limited to SMA-affected animals and carriers and always appears in context of the founder haplotype. The Ala variant found in healthy animals showed the expected 3-ketodihydrosphingosine reductase activity in an in vitro enzyme assay. Importantly, the Thr variant found in SMA animals showed no detectable activity. Surprisingly, in an in vivo assay the mutated gene complements the growth defect of a homologous yeast knockout strain as well as the healthy variant. This finding explains the viability of affected newborn calves and the later neuron-specific onset of the disease, which might be due to the high sensitivity of these neurons to changes in housekeeping functions. Taken together, the described mutation in FVT1 is a strong candidate for causality of SMA in cattle. This result provides an animal model for understanding the underlying mechanisms of the development of SMA and will allow efficient selection against the disease in cattle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420465      PMCID: PMC1868895          DOI: 10.1073/pnas.0607721104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Cell death and decreased synaptic protein expression in the ventral horn of Holstein-Friesian calves with spinal muscular atrophy.

Authors:  S Sisó; M Pumarola; I Ferrer
Journal:  J Comp Pathol       Date:  2003 Feb-Apr       Impact factor: 1.311

2.  SPTLC1 is mutated in hereditary sensory neuropathy, type 1.

Authors:  K Bejaoui; C Wu; M D Scheffler; G Haan; P Ashby; L Wu; P de Jong; R H Brown
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

3.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

Review 4.  Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.

Authors:  Kevin Talbot; Olaf Ansorge
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

5.  Juvenile spinal muscular atrophy: a new hexosaminidase deficiency phenotype.

Authors:  W G Johnson; H J Wigger; H R Karp; L M Glaubiger; L P Rowland
Journal:  Ann Neurol       Date:  1982-01       Impact factor: 10.422

6.  Ceramidase regulates synaptic vesicle exocytosis and trafficking.

Authors:  Jeffrey Rohrbough; Emma Rushton; Laura Palanker; Elvin Woodruff; Heinrich J G Matthies; Usha Acharya; Jairaj K Acharya; Kendal Broadie
Journal:  J Neurosci       Date:  2004-09-08       Impact factor: 6.167

7.  Construction of multilocus genetic linkage maps in humans.

Authors:  E S Lander; P Green
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Mapping of the bovine spinal muscular atrophy locus to Chromosome 24.

Authors:  Ivica Medugorac; Juliane Kemter; Ingolf Russ; Detlef Pietrowski; Stefan Nüske; Horst-Dieter Reichenbach; Wolfgang Schmahl; Martin Förster
Journal:  Mamm Genome       Date:  2003-06       Impact factor: 2.957

9.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.

Authors:  Agnes L Nishimura; Miguel Mitne-Neto; Helga C A Silva; Antônio Richieri-Costa; Susan Middleton; Duilio Cascio; Fernando Kok; João R M Oliveira; Tom Gillingwater; Jeanette Webb; Paul Skehel; Mayana Zatz
Journal:  Am J Hum Genet       Date:  2004-09-15       Impact factor: 11.025

Review 10.  Membrane dynamics and cell polarity: the role of sphingolipids.

Authors:  Dick Hoekstra; Olaf Maier; Johanna M van der Wouden; Tounsia Ait Slimane; Sven C D van IJzendoorn
Journal:  J Lipid Res       Date:  2003-03-16       Impact factor: 5.922

View more
  17 in total

1.  Tsc10p and FVT1: topologically distinct short-chain reductases required for long-chain base synthesis in yeast and mammals.

Authors:  Sita D Gupta; Kenneth Gable; Gongshe Han; Anna Borovitskaya; Luke Selby; Teresa M Dunn; Jeffrey M Harmon
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

Review 2.  An overview of sphingolipid metabolism: from synthesis to breakdown.

Authors:  Christopher R Gault; Lina M Obeid; Yusuf A Hannun
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.

Authors:  James C Dodge; Christopher M Treleaven; Joshua Pacheco; Samantha Cooper; Channa Bao; Marissa Abraham; Mandy Cromwell; S Pablo Sardi; Wei-Lien Chuang; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

Review 4.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

Review 5.  Approaches for probing and evaluating mammalian sphingolipid metabolism.

Authors:  Justin M Snider; Chiara Luberto; Yusuf A Hannun
Journal:  Anal Biochem       Date:  2019-03-24       Impact factor: 3.365

6.  Arachnomelia in Brown Swiss cattle maps to chromosome 5.

Authors:  Cord Drögemüller; Marco Rossi; Arcangelo Gentile; Stefania Testoni; Hannes Jörg; Gerald Stranzinger; Michaela Drögemüller; Marie-Louise Glowatzki-Mullis; Tosso Leeb
Journal:  Mamm Genome       Date:  2008-12-31       Impact factor: 2.957

7.  An unusual splice defect in the mitofusin 2 gene (MFN2) is associated with degenerative axonopathy in Tyrolean Grey cattle.

Authors:  Cord Drögemüller; Ursula Reichart; Torsten Seuberlich; Anna Oevermann; Martin Baumgartner; Kathrin Kühni Boghenbor; Michael H Stoffel; Claudia Syring; Mireille Meylan; Simone Müller; Mathias Müller; Birgit Gredler; Johann Sölkner; Tosso Leeb
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

8.  Artificial neural network inference (ANNI): a study on gene-gene interaction for biomarkers in childhood sarcomas.

Authors:  Dong Ling Tong; David J Boocock; Gopal Krishna R Dhondalay; Christophe Lemetre; Graham R Ball
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

9.  A missense mutation in TUBD1 is associated with high juvenile mortality in Braunvieh and Fleckvieh cattle.

Authors:  Hermann Schwarzenbacher; Johann Burgstaller; Franz R Seefried; Christine Wurmser; Monika Hilbe; Simone Jung; Christian Fuerst; Nora Dinhopl; Herbert Weissenböck; Birgit Fuerst-Waltl; Marlies Dolezal; Reinhard Winkler; Oskar Grueter; Ulrich Bleul; Thomas Wittek; Ruedi Fries; Hubert Pausch
Journal:  BMC Genomics       Date:  2016-05-25       Impact factor: 3.969

10.  Confirmation of a non-synonymous SNP in PNPLA8 as a candidate causal mutation for Weaver syndrome in Brown Swiss cattle.

Authors:  Elisabeth Kunz; Sophie Rothammer; Hubert Pausch; Hermann Schwarzenbacher; Franz R Seefried; Kaspar Matiasek; Doris Seichter; Ingolf Russ; Ruedi Fries; Ivica Medugorac
Journal:  Genet Sel Evol       Date:  2016-03-18       Impact factor: 4.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.